McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895–e1032

PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  CAS  PubMed  Google Scholar 

Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, Hartmann T (2013) Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer’s disease. Front Aging Neurosci 5:98

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galo J, Celli D, Colombo R (2021) Effect of sacubitril/valsartan on neurocognitive function: current status and future directions. Am J Cardiovasc Drugs 21(3):267–270

Article  CAS  PubMed  Google Scholar 

Docherty KF, Vaduganathan M, Solomon SD, McMurray JJV (2020) Sacubitril/valsartan: neprilysin inhibition 5 years after PARADIGM-HF. JACC Heart Fail 8(10):800–810

Article  PubMed  PubMed Central  Google Scholar 

Singh PK, Chen ZL, Ghosh D, Strickland S, Norris EH (2020) Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer’s patients. Neurobiol Dis 139:104833

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langenickel TH, Tsubouchi C, Ayalasomayajula S, Pal P, Valentin MA, Hinder M et al (2016) The effect of LCZ696 (sacubitril/valsartan) on amyloid-beta concentrations in cerebrospinal fluid in healthy subjects. Br J Clin Pharmacol 81(5):878–890

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schoenfeld HA, West T, Verghese PB, Holubasch M, Shenoy N, Kagan D et al (2017) The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-beta concentrations and clearance in the cynomolgus monkey. Toxicol Appl Pharmacol 323:53–65

Article  CAS  PubMed  Google Scholar 

El-Din Hussein AS, Abou-El Nour RKE, Khorshid OA, Osman AS (2023) Study of the possible effect of sacubitril/valsartan combination versus valsartan on the cognitive function in Alzheimer’s disease model in rats. Int J Immunopathol Pharmacol 37:3946320231161469

Article  CAS  PubMed  Google Scholar 

Hammadi SH, Hassan MA, Allam EA, Elsharkawy AM, Shams SS (2023) Effect of sacubitril/valsartan on cognitive impairment in colchicine-induced Alzheimer’s model in rats. Fundam Clin Pharmacol 37(2):275–286

Article  CAS  PubMed  Google Scholar 

Cannon JA, Shen L, Jhund PS, Kristensen SL, Kober L, Chen F et al (2017) Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. Eur J Heart Fail 19(1):129–137

Article  CAS  PubMed  Google Scholar 

Chen C, Ding L, Fu F, Xiao J (2023) Updated insights on dementia-related risk of sacubitril/valsartan: a real-world pharmacovigilance analysis. CNS Neurosci Ther 29(9):2548–2554

Article  PubMed  PubMed Central  Google Scholar 

Perlman A, Hirsh Raccah B, Matok I, Muszkat M (2018) Cognition- and dementia-related adverse effects with sacubitril-valsartan: analysis of the FDA adverse event report system database. J Card Fail 24(8):533–536

Article  CAS  PubMed  Google Scholar 

Bavry AA (2022) Efficacy and safety of sacubitril/valsartan compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction—perspective. American College of Cardiology Foundation. https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2022/08/25/03/38/PERSPECTIVE#references-for-article. Accessed 17 July 2023

Choi EK (2020) Cardiovascular research using the Korean national health information database. Korean Circ J 50(9):754–772

Article  PubMed  PubMed Central  Google Scholar 

Lee CJ, Lee JY, Han K, Kim DH, Cho H, Kim KJ et al (2022) Blood pressure levels and risks of dementia: a nationwide study of 4.5 million people. Hypertension 79(1):218–229

Article  CAS  PubMed  Google Scholar 

Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083–3107

Article  PubMed  PubMed Central  Google Scholar 

Gu J, Noe A, Chandra P, Al-Fayoumi S, Ligueros-Saylan M, Sarangapani R et al (2010) Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi). J Clin Pharmacol 50(4):401–414

Article  CAS  PubMed  Google Scholar 

Grewal PKA, Myserlis EP, Goldschmidt ME, Butler J, Skopicki HA, Kalogeropoulos AP (2023) Sacubitril/valsartan and cognitive outcomes in heart failure with reduced ejection fraction. JACC Adv 2(4):100372

Article  Google Scholar 

Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A et al (2020) Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium. Neurology 95(5):e519–e531

Article  PubMed  PubMed Central  Google Scholar 

Kwon HS, Jeong YW, Kim SH, Park KH, Seo SW, Na HR et al (2022) Annual incidence of dementia from 2003 to 2018 in metropolitan Seoul, Korea: a population-based study. J Clin Med 11(3):819

Article  PubMed  PubMed Central  Google Scholar 

Vishwanath S, Qaderi V, Steves CJ, Reid CM, Hopper I, Ryan J (2022) Cognitive decline and risk of dementia in individuals with heart failure: a systematic review and meta-analysis. J Card Fail 28(8):1337–1348

Article  PubMed  Google Scholar 

Kim W, Kim EJ (2018) Heart failure as a risk factor for stroke. J Stroke 20(1):33–45

Article  PubMed  PubMed Central  Google Scholar 

Kondo T, Abdul-Rahim AH, Talebi A, Abraham WT, Desai AS, Dickstein K et al (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. Eur Heart J 43(42):4469–4479

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Zhu Y, Ma Y, Hua R, Zhong B, Xie W (2022) Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol 79(14):1321–1335

Article  CAS  PubMed  Google Scholar 

Dallaire-Theroux C, Quesnel-Olivo MH, Brochu K, Bergeron F, O’Connor S, Turgeon AF et al (2021) Evaluation of intensive vs standard blood pressure reduction and association with cognitive decline and dementia: a systematic review and meta-analysis. JAMA Netw Open 4(11):e2134553

Article  PubMed  PubMed Central  Google Scholar